Seeing Is Believing
Currently out of the existing stock ratings of Young Li, 1 are a BUY (25%), 3 are a HOLD (75%).
Analyst Young Li, currently employed at JEFFERIES, carries an average stock price target met ratio of 25% that have a potential upside of 5.78% achieved within 16 days.
Young Li’s has documented 8 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CNMD, CONMED at 11-Oct-2022.
Analyst best performing recommendations are on CNMD (CONMED).
The best stock recommendation documented was for CNMD (CONMED) at 10/11/2022. The price target of $85 was fulfilled within 31 days with a profit of $8.8 (11.55%) receiving and performance score of 3.73.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$25
$7.75 (44.93%)
$37
20 days ago
(01-Nov-2024)
10/14 (71.43%)
$8.47 (51.24%)
110
Buy
$32
$14.75 (85.51%)
$61
1 years 3 months 12 days ago
(09-Aug-2023)
1/3 (33.33%)
$11.99 (59.92%)
73
Hold
$35
2 years 1 months 7 days ago
(14-Oct-2022)
0/2 (0%)
$8.78 (33.49%)
Hold
$46
$23.44 (103.90%)
$46
3 years 3 days ago
(18-Nov-2021)
0/2 (0%)
$5.44 (13.41%)
Buy
$65
$47.75 (276.81%)
$54
4 years 10 months 11 days ago
(10-Jan-2020)
5/6 (83.33%)
$15.2 (30.52%)
21
What Year was the first public recommendation made by Young Li?